Cargando…
(416) Heart Transplantation with Covid 19 Positive Donor Hearts
PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068084/ http://dx.doi.org/10.1016/j.healun.2023.02.431 |
_version_ | 1785018612688355328 |
---|---|
author | Wolfe, S.B. Singh, R. Paneitz, D.C. Asija, R. Rabi, S. Michel, E. D'Alessandro, D. Ganapathi, A. Osho, A. |
author_facet | Wolfe, S.B. Singh, R. Paneitz, D.C. Asija, R. Rabi, S. Michel, E. D'Alessandro, D. Ganapathi, A. Osho, A. |
author_sort | Wolfe, S.B. |
collection | PubMed |
description | PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes in recipients of hearts from COVID-19+ donors. METHODS: The Organ Procurement and Transplantation Network database was queried for all heart transplant recipients between January 1, 2020 and December 31, 2021. Recipients of COVID-19+ donor hearts were compared to recipients of COVID-19- donor hearts. Pediatric recipients, multiorgan transplants, donors without COVID-19 testing, and recipients allocated under the old heart allocation system were excluded. One to three propensity score matching was used to match COVID+ donor heart recipients to COVID- donor heart recipients. RESULTS: Over the study period, 4,621 heart transplant recipients met inclusion-exclusion criteria, including 62 recipients of COVID+ donor hearts. After matching on pre-transplant recipient and donor characteristics, the 59 COVID+ donor heart recipients were matched to 177 COVID- donor heart recipients. Baseline characteristics were similar following matching. Thirty-day survival was similar between groups (COVID- 95.5% vs. COVID+ 100.0%, log rank p=0.10) as was six-month survival (COVID- 93.2% vs. COVID+ 98.3%, log rank p=0.15; Figure 1). National COVID+ donor heart usage varied by region, with region 11 transplanting the largest proportion of COVID+ hearts [11/62 (17.7%)] and region 10 transplanting the least [1/62 (1.64%)]. COVID+ heart utilization per region was greatest in region 1 [7/249 (2.8%)] and least in region 10 [1/384 (0.26%)]. CONCLUSION: Thirty-day and six-month survival in recipients of COVID+ donor hearts is similar to that of COVID- donor hearts. These data should encourage increased utilization of COVID+ donor hearts. Further analyses are needed to determine if long-term outcomes are equivalent between groups. |
format | Online Article Text |
id | pubmed-10068084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100680842023-04-03 (416) Heart Transplantation with Covid 19 Positive Donor Hearts Wolfe, S.B. Singh, R. Paneitz, D.C. Asija, R. Rabi, S. Michel, E. D'Alessandro, D. Ganapathi, A. Osho, A. J Heart Lung Transplant Article PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes in recipients of hearts from COVID-19+ donors. METHODS: The Organ Procurement and Transplantation Network database was queried for all heart transplant recipients between January 1, 2020 and December 31, 2021. Recipients of COVID-19+ donor hearts were compared to recipients of COVID-19- donor hearts. Pediatric recipients, multiorgan transplants, donors without COVID-19 testing, and recipients allocated under the old heart allocation system were excluded. One to three propensity score matching was used to match COVID+ donor heart recipients to COVID- donor heart recipients. RESULTS: Over the study period, 4,621 heart transplant recipients met inclusion-exclusion criteria, including 62 recipients of COVID+ donor hearts. After matching on pre-transplant recipient and donor characteristics, the 59 COVID+ donor heart recipients were matched to 177 COVID- donor heart recipients. Baseline characteristics were similar following matching. Thirty-day survival was similar between groups (COVID- 95.5% vs. COVID+ 100.0%, log rank p=0.10) as was six-month survival (COVID- 93.2% vs. COVID+ 98.3%, log rank p=0.15; Figure 1). National COVID+ donor heart usage varied by region, with region 11 transplanting the largest proportion of COVID+ hearts [11/62 (17.7%)] and region 10 transplanting the least [1/62 (1.64%)]. COVID+ heart utilization per region was greatest in region 1 [7/249 (2.8%)] and least in region 10 [1/384 (0.26%)]. CONCLUSION: Thirty-day and six-month survival in recipients of COVID+ donor hearts is similar to that of COVID- donor hearts. These data should encourage increased utilization of COVID+ donor hearts. Further analyses are needed to determine if long-term outcomes are equivalent between groups. Published by Elsevier Inc. 2023-04 2023-04-03 /pmc/articles/PMC10068084/ http://dx.doi.org/10.1016/j.healun.2023.02.431 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wolfe, S.B. Singh, R. Paneitz, D.C. Asija, R. Rabi, S. Michel, E. D'Alessandro, D. Ganapathi, A. Osho, A. (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title | (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title_full | (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title_fullStr | (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title_full_unstemmed | (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title_short | (416) Heart Transplantation with Covid 19 Positive Donor Hearts |
title_sort | (416) heart transplantation with covid 19 positive donor hearts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068084/ http://dx.doi.org/10.1016/j.healun.2023.02.431 |
work_keys_str_mv | AT wolfesb 416hearttransplantationwithcovid19positivedonorhearts AT singhr 416hearttransplantationwithcovid19positivedonorhearts AT paneitzdc 416hearttransplantationwithcovid19positivedonorhearts AT asijar 416hearttransplantationwithcovid19positivedonorhearts AT rabis 416hearttransplantationwithcovid19positivedonorhearts AT michele 416hearttransplantationwithcovid19positivedonorhearts AT dalessandrod 416hearttransplantationwithcovid19positivedonorhearts AT ganapathia 416hearttransplantationwithcovid19positivedonorhearts AT oshoa 416hearttransplantationwithcovid19positivedonorhearts |